PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954608
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954608
Legionella Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of Legionella testing Market
The global Legionella testing market was valued at USD 379.3 million in 2025 and is projected to grow from USD 415.1 million in 2026 to USD 883.8 million by 2034, exhibiting a CAGR of 9.90% during the forecast period (2026-2034). The market is witnessing steady expansion due to the rising prevalence of Legionnaires' disease, increasing awareness regarding waterborne infections, and the growing adoption of rapid diagnostic technologies. In 2025, North America dominated the market with a 39.50% share, supported by strong regulatory frameworks and advanced healthcare infrastructure.
Market Overview
Legionella is a bacterial species commonly found in freshwater environments such as ponds, lakes, showers, hot tubs, cooling towers, and water storage systems. Under favorable conditions, particularly temperatures between 20°C and 40°C, the bacteria multiply and can cause respiratory illnesses such as Legionnaires' disease and Pontiac fever.
Growing public health concerns, especially in developed countries, have led to stringent regulations for regular water testing. Following the increased prevalence of Legionella infections in the U.S. since 1997, authorities implemented mandatory testing of water systems. According to WHO data (2022), approximately 10-15 cases per million population are detected annually across the U.S., Europe, and Australia.
Impact of COVID-19 on the Market
During the COVID-19 pandemic, the market experienced temporary slow growth due to manufacturing disruptions, supply chain challenges, and healthcare systems prioritizing coronavirus testing. Additionally, similarities in clinical symptoms between COVID-19 and Legionnaires' disease resulted in reduced Legionella testing rates.
However, the post-pandemic period has created renewed growth opportunities. Prolonged building closures led to stagnant water systems, increasing the risk of Legionella proliferation. In 2021, the CDC recommended testing water systems such as hot tubs and storage tanks before reopening facilities. This has significantly boosted demand for Legionella testing solutions in 2025 and beyond.
Market Trends
Growing Adoption of Rapid Testing Methods
The market is witnessing a shift from traditional culture methods to advanced diagnostic technologies such as Urine Antigen Testing (UAT) and Polymerase Chain Reaction (PCR).
- PCR testing offers high sensitivity (95-99%) and detects multiple Legionella serotypes with faster turnaround times.
- Real-time PCR kits are increasingly adopted for hospital-based and onsite testing.
- Rapid molecular diagnostics are improving accuracy and enabling early disease detection.
These technological advancements are key contributors to the projected growth from USD 415.1 million in 2026 to USD 883.8 million by 2034.
Market Growth Drivers
1. Rising Prevalence of Legionnaires' Disease
Increasing global cases are driving demand for testing kits. The U.S. Department of Labor reports approximately 6,000 Legionella cases annually in the U.S. Hospital-acquired infections are also a concern. A study in Taiwan revealed that 63% of surveyed hospitals tested positive for Legionella pneumophila in their water systems.
2. Stringent Regulatory Policies
Governments worldwide are enforcing water management guidelines. The WHO provides seven principal guidance documents for risk management. In Europe, the European Working Group for Legionella Infections (EWGLI) supports surveillance programs. Such regulatory emphasis is strengthening market growth.
Market Restraints
Despite strong growth prospects, limited awareness in underdeveloped countries restrains market expansion. In countries like India, Legionella infections are often underdiagnosed due to overlapping symptoms with pneumonia and tuberculosis. High costs of advanced diagnostics such as real-time PCR and lack of infrastructure also hinder adoption in emerging markets.
Segmentation Analysis
By Type
The market is segmented into culture media, urine antigen testing, PCR, serology tests, and direct fluorescent antibody methods.
- Urine Antigen Testing (UAT) held the largest market share of 42.12% in 2026, due to affordability and same-day results. However, it primarily detects LP1 species.
- PCR testing is projected to witness the fastest growth due to superior sensitivity and accuracy.
By End-User
Segments include hospitals & clinics, clinical laboratories, and environmental testing sites.
- Clinical laboratories dominated the market and are expected to maintain leadership due to rising disease prevalence and advanced diagnostic penetration.
- Environmental testing is expanding rapidly due to onsite testing solutions and regulatory mandates.
Regional Insights
North America
The market size in North America reached USD 149.65 million in 2025. Strong regulatory enforcement, high awareness, and a large geriatric population drive demand.
Europe
Europe holds the second-largest share due to increasing outbreaks and adoption of PCR testing.
Asia Pacific
Asia Pacific is projected to grow at the highest CAGR through 2034, supported by improving healthcare infrastructure and rising awareness.
Competitive Landscape
The market is consolidated, with key players including Abbott, Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, IDEXX Corporation, BD, bioMerieux, and Eurofins Scientific. Companies are focusing on mergers, acquisitions, and product launches to expand their portfolios.
Conclusion
The global Legionella testing market is set for strong growth, rising from USD 379.3 million in 2025 to USD 883.8 million by 2034, driven by increasing disease prevalence, stringent water safety regulations, and rapid adoption of advanced diagnostic technologies such as PCR and UAT. While limited awareness in emerging economies poses challenges, expanding regulatory frameworks and technological innovations are expected to sustain long-term market expansion. As governments and healthcare institutions prioritize water safety and infection prevention, Legionella testing will remain a critical component of global public health strategies.
Segmentation
By Type
- Culture Media
- Urine Antigen Testing (UAT)
- Polymerase Chain Reaction (PCR)
- Serology
- Direct Fluorescent Antibody (DFA) Test
By End-User
- Hospitals & Clinics
- Clinical Laboratories
- Others
By Geography
- North America (By Type, End-User, and Country)
- U.S.
- Canada
- Europe (By Type, End-User, and Country/Sub region)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific (By Type, End-User, and Country/Sub region)
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Rest of Asia Pacific
- Latin America (By Type, End-User, and Country/Sub region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, End-User, and Country/Sub region)
- South Africa
- GCC
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Legionella Infection, By Key Countries
- 4.2. Key Industry Developments - Merges, Acquisitions and Partnerships
- 4.3. Technological Advancements in Legionella Testing Kits
- 4.4. Regulatory Scenario, By Key Countries
- 4.5. Impact of COVID-19 on the Market
5. Global Legionella Testing Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Culture Media
- 5.1.2. Urine Antigen Testing (UAT)
- 5.1.3. Polymerase Chain Reaction (PCR)
- 5.1.4. Serology
- 5.1.5. Direct Fluorescent Antibody Test (DFA)
- 5.2. Market Analysis, Insights and Forecast - By End User
- 5.2.1. Hospitals & Clinics
- 5.2.2. Clinical Laboratories
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - By Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Latin America
- 5.3.5. Middle East & Africa
6. North America Legionella Testing Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Culture Media
- 6.1.2. Urine Antigen Testing (UAT)
- 6.1.3. Polymerase Chain Reaction (PCR)
- 6.1.4. Serology
- 6.1.5. Direct Fluorescent Antibody Test (DFA)
- 6.2. Market Analysis, Insights and Forecast - By End User
- 6.2.1. Hospitals & Clinics
- 6.2.2. Clinical Laboratories
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast - By Country
- 6.3.1. U.S.
- 6.3.2. Canada
7. Europe Legionella Testing Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Culture Media
- 7.1.2. Urine Antigen Testing (UAT)
- 7.1.3. Polymerase Chain Reaction (PCR)
- 7.1.4. Serology
- 7.1.5. Direct Fluorescent Antibody Test (DFA)
- 7.2. Market Analysis, Insights and Forecast - By End User
- 7.2.1. Hospitals & Clinics
- 7.2.2. Clinical Laboratories
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.3.1. U.K
- 7.3.2. Germany
- 7.3.3. France
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Rest of Europe
8. Asia Pacific Legionella Testing Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Culture Media
- 8.1.2. Urine Antigen Testing (UAT)
- 8.1.3. Polymerase Chain Reaction (PCR)
- 8.1.4. Serology
- 8.1.5. Direct Fluorescent Antibody Test (DFA)
- 8.2. Market Analysis, Insights and Forecast - By End User
- 8.2.1. Hospitals & Clinics
- 8.2.2. Clinical Laboratories
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.3.4. India
- 8.3.5. Australia
- 8.3.6. Taiwan
- 8.3.7. Indonesia
- 8.3.8. Rest of Asia Pacific
9. Latin America Legionella Testing Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Culture Media
- 9.1.2. Urine Antigen Testing (UAT)
- 9.1.3. Polymerase Chain Reaction (PCR)
- 9.1.4. Serology
- 9.1.5. Direct Fluorescent Antibody Test (DFA)
- 9.2. Market Analysis, Insights and Forecast - By End User
- 9.2.1. Hospitals & Clinics
- 9.2.2. Clinical Laboratories
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.3.1. Brazil
- 9.3.2. Mexico
- 9.3.3. Rest of Latin America
10. Middle East & Africa Legionella Testing Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Culture Media
- 10.1.2. Urine Antigen Testing (UAT)
- 10.1.3. Polymerase Chain Reaction (PCR)
- 10.1.4. Serology
- 10.1.5. Direct Fluorescent Antibody Test (DFA)
- 10.2. Market Analysis, Insights and Forecast - By End User
- 10.2.1. Hospitals & Clinics
- 10.2.2. Clinical Laboratories
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.3.1. GCC
- 10.3.2. South Africa
- 10.3.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Quidel Corporation
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. financials (Based on Availability)
- 11.2.2. Abbott
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. financials (Based on Availability)
- 11.2.3. Merck KGaA
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. financials (Based on Availability)
- 11.2.4. Bio-Rad Laboratories, Inc.
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. financials (Based on Availability)
- 11.2.5. Thermo Fisher Scientific Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. financials (Based on Availability)
- 11.2.6. BD
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. financials (Based on Availability)
- 11.2.7. bioMerieux
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. financials (Based on Availability)
- 11.2.8. IDEXX Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. financials (Based on Availability)
- 11.2.9. Eurofins Scientific
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. financials (Based on Availability)
- 11.2.1. Quidel Corporation
List of Tables
- Table 1: Global Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
- Table 2: Global Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
- Table 3: Global Legionella Testing Market Revenue (USD Million) Forecast, by Region, 2021-2034
- Table 4: North America Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
- Table 5: North America Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
- Table 6: North America Legionella Testing Market Revenue (USD Million) Forecast, by Country, 2021-2034
- Table 7: Europe Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
- Table 8: Europe Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
- Table 9: Europe Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
- Table 10: Asia Pacific Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
- Table 11: Asia Pacific Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
- Table 12: Asia Pacific Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
- Table 13: Latin America Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
- Table 14: Latin America Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
- Table 15: Latin America Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
- Table 16: Middle East & Africa Legionella Testing Market Revenue (USD Million) Forecast, by Type, 2021-2034
- Table 17: Middle East & Africa Legionella Testing Market Revenue (USD Million) Forecast, by End-user, 2021-2034
- Table 18: Middle East & Africa Legionella Testing Market Revenue (USD Million) Forecast, by Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Legionella Testing Market Revenue Breakdown (USD Million, %) by Region, 2025 & 2034
- Figure 2: Global Legionella Testing Market Value Share (%), by Type, 2025 & 2034
- Figure 3: Global Legionella Testing Market Forecast (USD Million), by Culture Media, 2021-2034
- Figure 4: Global Legionella Testing Market Forecast (USD Million), by Urine Antigen Testing (UAT), 2021-2034
- Figure 5: Global Legionella Testing Market Forecast (USD Million), by Polymerase Chain Reaction (PCR), 2021-2034
- Figure 6: Global Legionella Testing Market Forecast (USD Million), by Serology, 2021-2034
- Figure 7: Global Legionella Testing Market Forecast (USD Million), by Direct Fluorescent Antibody Test (DFA), 2021-2034
- Figure 8: Global Legionella Testing Market Value Share (%), by End-user, 2025 & 2034
- Figure 09: Global Legionella Testing Market Value (USD Million), by Region, 2025 & 2034
- Figure 10: North America Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
- Figure 11: North America Legionella Testing Market Value Share (%), by Type, 2025
- Figure 12: North America Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
- Figure 13: North America Legionella Testing Market Value Share (%), by End-user, 2025
- Figure 14: North America Legionella Testing Market Value (USD Million), by Country, 2025 & 2034
- Figure 15: North America Legionella Testing Market Value Share (%), by Country, 2025
- Figure 16: Europe Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
- Figure 17: Europe Legionella Testing Market Value Share (%), by Type, 2025
- Figure 18: Europe Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
- Figure 19: Europe Legionella Testing Market Value Share (%), by End-user, 2025
- Figure 20: Europe Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
- Figure 22: Asia Pacific Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
- Figure 23: Asia Pacific Legionella Testing Market Value Share (%), by Type, 2025
- Figure 24: Asia Pacific Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
- Figure 25: Asia Pacific Legionella Testing Market Value Share (%), by End-user, 2025
- Figure 26: Asia Pacific Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
- Figure 27: Asia Pacific Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
- Figure 28: Latin America Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
- Figure 29: Latin America Legionella Testing Market Value Share (%), by Type, 2025
- Figure 30: Latin America Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
- Figure 31: Latin America Legionella Testing Market Value Share (%), by End-user, 2025
- Figure 32: Latin America Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
- Figure 33: Latin America Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
- Figure 34: Middle East & Africa Legionella Testing Market Value (USD Million), by Type, 2025 & 2034
- Figure 35: Middle East & Africa Legionella Testing Market Value Share (%), by Type, 2025
- Figure 36: Middle East & Africa Legionella Testing Market Value (USD Million), by End-user, 2025 & 2034
- Figure 37: Middle East & Africa Legionella Testing Market Value Share (%), by End-user, 2025
- Figure 38: Middle East & Africa Legionella Testing Market Value (USD Million), by Country/ Sub-region, 2025 & 2034
- Figure 39: Middle East & Africa Legionella Testing Market Value Share (%), by Country/ Sub-region, 2025
- Figure 40: Global Legionella Testing Market Share (%), By Company, 2025
